Physician

Eric C. Santos, M.D.

According to 2025 Medicare claims, Eric Santos, M.D. (NPI: 1174700256) practices hematology/oncology in the Grand Rapids-Wyoming-Kentwood, MI market, with the plurality of this provider's patient population coming from Kent, MI. This provider's primary affiliated billing organization is CANCER & HEMATOLOGY CENTERS OF WESTERN MI, P.C. (NPI: 1528018389; TIN: 382777354) and primary practice location at 49503-2563. Santos is affiliated with the West Michigan Accountable Care Organization, LLC (ACO ID: A4626), participating under the MSSP model.

Santos' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 312 traditional Medicare patients, billed 104,743 HCPCS/CPT codes, and received $2,237,625 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 875 prescription claims across 198 beneficiaries totaling $2,783,938 in drug costs, led by Tagrisso (Osimertinib Mesylate). DME data shows 34 claims. Open Payments data shows 17 records totaling $78,399. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $899,650 to $2,783,938. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $5,548 to $1,674.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	498	55,309	$1,388,652
2016	512	167,998	$1,923,188
2017	535	191,011	$2,664,795
2018	519	171,653	$3,557,420
2019	464	145,235	$3,888,028
2020	387	116,703	$3,492,718
2021	363	102,941	$3,153,955
2022	356	103,245	$2,500,394
2023	308	93,254	$2,282,078
2024	312	104,743	$2,237,625

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	203	927	$899,650
2016	223	893	$1,047,669
2017	226	868	$1,015,947
2018	212	840	$1,130,785
2019	212	757	$1,476,559
2020	180	758	$890,920
2021	178	658	$1,342,475
2022	184	677	$1,602,798
2023	175	665	$1,720,649
2024	198	875	$2,783,938

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	46	$5,177
2016	N/R	91	$24,348
2017	N/R	N/R	N/R
2018	N/R	34	$5,200
2019	N/R	11	$141
2020	N/R	32	$1,432
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	34	$1,521

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	84	296	$90
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	86	251	$88
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	94	171	$61
36415	Insertion of needle into vein for collection of blood sample	85	327	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	82	318	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Tagrisso	Osimertinib Mesylate	79	2,316	$1,291,936
Mekinist	Trametinib Dimethyl Sulfoxide	22	660	$327,450
Tabrecta	Capmatinib Hydrochloride	12	336	$275,448
Tafinlar	Dabrafenib Mesylate	21	630	$268,844
Gilotrif	Afatinib Dimaleate	18	540	$197,261

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	20	$1,286
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	14	$235

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	11	$230	ARRAY BIOPHARMA INC
Research Payments	Reported research-related payment or transfer-of-value amount.	6	$78,168	AstraZeneca Pharmaceuticals LP
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Eric C. Santos, M.D.?

Tedicare shows public-source Medicare data for Eric C. Santos, M.D. (NPI 1174700256), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Eric C. Santos, M.D. have ACO affiliation data?

Eric C. Santos, M.D. is shown with ACO affiliation data for West Michigan Accountable Care Organization, LLC (MSSP, ACO ID A4626).

What billing organization is linked to Eric C. Santos, M.D.?

Eric C. Santos, M.D. is linked to CANCER & HEMATOLOGY CENTERS OF WESTERN MI, P.C. (billing NPI 1528018389) in the available physician profile data.

Does Eric C. Santos, M.D. have Open Payments data?

Eric C. Santos, M.D. has 17 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.